NCT06431477View on ClinicalTrials.gov

Efficacy and Safety of Telmisartan Compared With Losartan

PHASE4RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Diabetic NephropathiesHypertension
Interventions
DRUG

telmisartan

QD, PO

DRUG

Losartan

QD, PO

Trial Locations (1)

Unknown

RECRUITING

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT06431477 - Efficacy and Safety of Telmisartan Compared With Losartan | Biotech Hunter | Biotech Hunter